IRIS
MONTAGNANI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.807
NA - Nord America 8.129
AS - Asia 2.320
SA - Sud America 377
AF - Africa 131
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 17
Totale 24.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.032
IT - Italia 3.832
GB - Regno Unito 2.739
IE - Irlanda 2.067
DE - Germania 1.031
CN - Cina 958
SE - Svezia 879
RU - Federazione Russa 823
SG - Singapore 714
UA - Ucraina 622
FR - Francia 617
FI - Finlandia 532
BR - Brasile 292
VN - Vietnam 194
NL - Olanda 180
ES - Italia 116
IN - India 107
AT - Austria 68
BE - Belgio 67
CA - Canada 67
IR - Iran 56
CZ - Repubblica Ceca 48
TR - Turchia 47
CI - Costa d'Avorio 44
HK - Hong Kong 40
PL - Polonia 31
CH - Svizzera 22
AR - Argentina 21
PH - Filippine 19
ZA - Sudafrica 17
EU - Europa 16
ID - Indonesia 16
PK - Pakistan 16
AU - Australia 15
CO - Colombia 15
EC - Ecuador 14
MX - Messico 14
LT - Lituania 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
JP - Giappone 12
LV - Lettonia 12
DK - Danimarca 11
EG - Egitto 11
PE - Perù 11
PT - Portogallo 11
RO - Romania 11
BD - Bangladesh 10
BG - Bulgaria 10
NG - Nigeria 10
VE - Venezuela 10
AZ - Azerbaigian 9
KR - Corea 9
AL - Albania 8
DZ - Algeria 8
EE - Estonia 8
MA - Marocco 8
TW - Taiwan 8
UG - Uganda 8
UZ - Uzbekistan 8
CL - Cile 7
NO - Norvegia 7
SA - Arabia Saudita 7
SK - Slovacchia (Repubblica Slovacca) 7
ET - Etiopia 6
GR - Grecia 6
IQ - Iraq 6
LU - Lussemburgo 6
NZ - Nuova Zelanda 6
PA - Panama 6
TN - Tunisia 6
AM - Armenia 5
CY - Cipro 5
HR - Croazia 5
JM - Giamaica 5
LK - Sri Lanka 5
MY - Malesia 5
BO - Bolivia 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MK - Macedonia 4
MN - Mongolia 4
BW - Botswana 3
GE - Georgia 3
JO - Giordania 3
KE - Kenya 3
KH - Cambogia 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
SN - Senegal 3
UY - Uruguay 3
BY - Bielorussia 2
GH - Ghana 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
QA - Qatar 2
RS - Serbia 2
SV - El Salvador 2
Totale 24.786
Salva come PNG Salva come JPEG
Città #
Southend 2.391
Dublin 2.021
Chandler 1.113
Santa Clara 802
Ashburn 567
Fairfield 556
Jacksonville 505
Siena 505
Munich 456
Milan 415
Helsinki 408
Ann Arbor 365
Singapore 349
Princeton 303
Woodbridge 282
Beijing 251
Wilmington 241
Seattle 222
Rome 220
Florence 205
New York 188
Cambridge 187
Nanjing 185
Dong Ket 182
Houston 158
Menlo Park 136
Boardman 107
Málaga 93
Shanghai 92
San Mateo 82
Düsseldorf 78
Los Angeles 73
Nuremberg 66
Nanchang 63
Brussels 62
Turin 61
Dearborn 60
Lauterbourg 59
Moscow 59
Frankfurt am Main 50
Naples 50
Portsmouth 50
Lancaster 49
Bologna 48
Fremont 48
Brescia 45
San Diego 45
Abidjan 44
Shenyang 41
Vienna 41
Washington 39
London 37
Redwood City 34
Genoa 32
Toronto 32
Catania 31
Hebei 27
Guangzhou 26
Brno 25
Changsha 25
Izmir 24
Padova 24
Tianjin 24
Kunming 23
Chicago 22
Council Bluffs 21
Jiaxing 21
Dallas 20
Venezia 20
Falkenstein 19
Hong Kong 19
Jinan 19
Lappeenranta 19
San Francisco 19
Palermo 18
São Paulo 18
Bari 17
Hefei 17
Norwalk 17
Stockholm 17
Newark 16
Nottingham 16
Paris 16
Perugia 16
Figline Valdarno 15
Hangzhou 15
Salerno 15
Athens 14
Pisa 14
Amsterdam 13
Karaj 13
Prague 13
Tehran 13
Trieste 13
Zhengzhou 13
Bergamo 12
Ningbo 12
Philadelphia 12
Riga 12
Zurich 12
Totale 15.660
Salva come PNG Salva come JPEG
Nome #
Utilizzo di dalbavancina nella terapia delle infezioni osteoarticolari 1.038
Staphylococcus aureus vaccine preclinical and clinical development: current state of the art 467
"EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY" 385
MENINGITE VIRALE DA HHV7. DESCRIZIONE DI UN CASO IN ADULTO IMMUNOCOMPETENTE 343
Analisi di clonalità di isolati di Streptococcus pyogenes resistenti ai macrolidi: fluttuazioni della dinamica di popolazione negli ultimi 8 anni 292
UTILIZZO DI MILTEFOSINA IN PAZIENTE CON LEISHMANIOSI MUCOSA ED INFEZIONE DA HIV 275
Crisi comiziale generalizzata in giovane paziente proveniente dal Togo 267
Analisi della sensibilità a penicillina in isolati comunitari di Streptococcus pneumoniae: implicazioni cliniche in relazione alle concentrazioni minime inibenti 251
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 239
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 230
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 227
Genetic mechanisms of critical illness in COVID-19 226
Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenes 219
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 209
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 208
Peripheral biomarkers' panel for severe COVID-19 patients 208
Evolution of macrolide resistance in streptococcus pyogenes over 14 years in an area of central Italy 198
Analisi preliminare sull’impatto clinico-organizzativo della gestione delle ABSSSI: focus sui criteri di dimissione precoce 196
Case Report: Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy 194
Evaluation and Optimization of an ELISA Procedure to Quantify Antibodies Against Pneumococcal Polysaccharides Included in the 13-Valent Conjugate Vaccine 191
Pediatric spinal epidural abscess in an immunocompetent host without risk factors: Case report and review of the literature 190
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 189
First report of spondylodiscitis due to vancomycin heteroresistant Staphylococcus capitis in immunocompetent host 189
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 188
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 188
Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin 182
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 177
Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients 175
Phacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological study 173
Pathogen-sugar interactions revealed by universal saturation transfer analysis 172
Un caso di “insolita” spondilodiscite da Staphylococcus capitis 172
Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance. 170
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 169
Strategie di vaccinazione anti-pneumococcica nel paziente adulto HIV-positivo: confronto fra vaccino coniugato 13-valente e vaccino polisaccaridico 23-valente 168
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia. 167
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 166
Meningite postchirurgica e infezione di cute e tessuti molli da Acinetobacter baumannii extensively drug resistant (XDR) 165
Prevalence of M75 Streptococcus Pyogenes strains harboring slaa gene in patients affected by pediatric obstructive sleep apnea syndrome in Central Italy 165
Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit 164
Serotype distribution, clonality and antimicrobial resistance of invasive pneumococcal isolates in a central Italian region: implications for vaccine strategies 163
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region 160
Prognostic bioindicators in severe COVID-19 patients 157
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 156
Mapping the human genetic architecture of COVID-19 155
MIASI CAVITARIA A LOCALIZZAZIONE NASALE DA OESTRUS OVIS: UN CASO CLINICO 154
Clinical and microbiological features of acute bacterial conjunctivitis at the primary eye care unit in a hospital of central Italy 154
ERADICAZIONE DI INFEZIONE DA HCV DOPO TRATTAMENTO DI 8 SETTIMANE CON GRAZOPREVIR/ELBASVIR: CASE REPORT 153
Clinical and microbiological features of acute bacterialconjunctivitis at the primary eye care unit in a hospital of centralItaly 152
Decline of Prevalence of Resistance Associated Substitutions to NS3 and NS5A inhibitors at DAA-failure in Hepatitis C Virus in Italy over the years 2015 to 2018 151
Approccio perinatale al neonato che ha presentato malessere fetale 148
A first update on mapping the human genetic architecture of COVID-19 147
Risposta immunitaria a lungo termine dopo vaccinazione antipneumococcica con vaccino coniugato 13-valente o vaccino polisaccaridico 23-valente in adulti HIV positivi 147
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: a cohort study 144
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 143
Serial KL-6 measurements in COVID-19 patients 143
Clindamycin-resistant Streptococcus pneumoniae 142
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 142
Antimicrobial Susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: Surveillance from 1993 to 2004 in Central Italy 140
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 140
Valutazione microbiologica del rischio infettivo nella chirurgia della cataratta 139
Evoluzione ed efficace controllo di un vasto focolaio epidemico nosocomiale da Klebsiella pneumoniae produttrice di carbapenemasi in un’area Neurochirurgica: lezioni apprese. 138
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 138
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 137
Descrizione di un'epidemia da Enterobacteriaceae multiresistenti in un'unità di terapia intensiva neonatale 136
Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006 136
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 136
Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents 135
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 133
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 133
PATOGENI COLONIZZANTI IL NASOFARINGE DI SOGGETTI HIV POSITIVI E HIV NEGATIVI 132
Identification of a human immunodominant B-cell epitope within the immunoglobulin A1 protease of Streptococcus pneumoniae 132
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management 132
null 131
Diagnosi di sarcoidosi in nuova diagnosi di HIV 130
Discovery of new Mycoplasma pneumoniae antigens by use of a whole genome lambda display library 129
Decline of Prevalence of Resistance Associated Substitutions to NS3 and NS5A inhibitors at DAA-failure in Hepatitis C Virus in Italy over the years 2015 to 2018 129
Sierotipizzazione di isolati invasivi di Streptococcus pneumoniae: utilità della PCR multiplex nella sorveglianza epidemiologica 126
Use of recombinant chimeric antigens for the serodiagnosis of Mycoplasma pneumoniae infection 125
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 123
Mycobacterium chimaera 123
Epidemiologia delle chemioresistenze di Streptococcus pneumoniae nell’area senese: 1992-1998 120
Resistenza ai beta-lattamici in Streptococcus pneumoniae: 10 anni di sorveglianza nell’area senese 119
An explainable model of host genetic interactions linked to COVID-19 severity 117
Long-term immune response to 13-valent Pneumococcal Conjugate Vaccine versus 23-valent Polysaccharide Vaccine in HIV-1 infected adults 117
Ridotta sensibilità a penicillina in Streptococcus pneumoniae: analisi microbiologica di ceppi di recente isolamento 116
Resistenza ai macrolidi in isolati clinici di Streptococcus pyogenes 116
Protective Activity of the CnaBE3 Domain Conserved among Staphylococcus aureus Sdr Proteins 116
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: an ARCA cohort study 116
Sensibilità a macrolidi e penicillina in Streptococcus pyogenes e Streptococcus pneumoniae nell’ultimo decennio: inversione di tendenza dopo il 2001 115
Meningite purulenta a decorso atipico in età pediatrica 113
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine versus 23-Valent Polysaccharide Vaccine In HIV-Infected Adults 113
Penicillino-resistenza in ceppi di Streptococcus pneumoniae isolati nella provincia di Siena 113
A complex outbreak of multiresistant Enterobacteriaceae producing the acquired AmpC-type beta-lactamase FOX-7 in a neonatal intensive care unit setting 112
Epidemiologia delle chemioresistenze di Streptococcus pneumoniae in una popolazione pediatrica della provincia di Siena 111
Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-years period of decreased macrolide susceptibility rates 111
WES profiling of COVID-19 111
Un raro caso di osteomielite da Moraxella osloensis e Staphylococcus capitis in giovane paziente immunocompetente 111
Sierotipizzazione, clonalità e chemiosensibilità di isolati invasivi di Streptococcus pneumoniae nell'area senese: basi per una corretta strategia vaccinale” 110
Chemiosensibilità e clonalità di isolati di Neisseria meningitidis nell'area senese 110
Penicillino-resistenza in 403 ceppi di Streptococcus pneumoniae isolati nella provincia di Siena (1992-1998) 110
Totale 17.233
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.317
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020543 0 0 0 0 0 0 0 0 0 279 95 169
2020/20212.444 78 194 35 198 231 244 72 324 351 162 221 334
2021/20222.498 185 264 142 176 152 89 113 124 130 206 308 609
2022/20234.308 250 458 509 519 364 711 228 375 351 171 208 164
2023/20244.411 141 114 404 291 213 977 1.262 171 71 205 235 327
2024/20256.519 392 415 948 436 1.039 703 774 673 901 238 0 0
Totale 25.534